ITMI20011321A0 - Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del - Google Patents

Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del

Info

Publication number
ITMI20011321A0
ITMI20011321A0 IT2001MI001321A ITMI20011321A ITMI20011321A0 IT MI20011321 A0 ITMI20011321 A0 IT MI20011321A0 IT 2001MI001321 A IT2001MI001321 A IT 2001MI001321A IT MI20011321 A ITMI20011321 A IT MI20011321A IT MI20011321 A0 ITMI20011321 A0 IT MI20011321A0
Authority
IT
Italy
Prior art keywords
apomorphine
useful
treatment
pharmaceutical composition
transdermal administration
Prior art date
Application number
IT2001MI001321A
Other languages
English (en)
Inventor
Maria Rosa Gasco
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Priority to IT2001MI001321A priority Critical patent/ITMI20011321A1/it
Publication of ITMI20011321A0 publication Critical patent/ITMI20011321A0/it
Priority to DE60200531T priority patent/DE60200531D1/de
Priority to EP02013398A priority patent/EP1270007B1/en
Priority to AT02013398T priority patent/ATE267600T1/de
Publication of ITMI20011321A1 publication Critical patent/ITMI20011321A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT2001MI001321A 2001-06-22 2001-06-22 Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del ITMI20011321A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT2001MI001321A ITMI20011321A1 (it) 2001-06-22 2001-06-22 Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del
DE60200531T DE60200531D1 (de) 2001-06-22 2002-06-19 Mikroemulsionen zur transdermalen Verabreichung von Apomorphin für die Behandlung von Morbus Parkinson
EP02013398A EP1270007B1 (en) 2001-06-22 2002-06-19 Microemulsions for the transdermal administration of apomorphine, for the treatment of Parkinson's disease
AT02013398T ATE267600T1 (de) 2001-06-22 2002-06-19 Mikroemulsionen zur transdermalen verabreichung von apomorphin für die behandlung von morbus parkinson

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001321A ITMI20011321A1 (it) 2001-06-22 2001-06-22 Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del

Publications (2)

Publication Number Publication Date
ITMI20011321A0 true ITMI20011321A0 (it) 2001-06-22
ITMI20011321A1 ITMI20011321A1 (it) 2002-12-22

Family

ID=11447920

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001MI001321A ITMI20011321A1 (it) 2001-06-22 2001-06-22 Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del

Country Status (4)

Country Link
EP (1) EP1270007B1 (it)
AT (1) ATE267600T1 (it)
DE (1) DE60200531D1 (it)
IT (1) ITMI20011321A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008039864A1 (en) * 2006-09-26 2008-04-03 Novavax, Inc. Emulsion formulations for transdermal delivery of poorly water soluble active agents
US9918934B2 (en) * 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles
EP2545905A1 (en) * 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited A new therapeutical composition containing apomorphine as active ingredient
CN107693486A (zh) * 2012-06-05 2018-02-16 纽罗德姆有限公司 包含阿朴吗啡和有机酸的组合物及其用途
CN112074274B (zh) * 2018-03-19 2024-03-26 艾匹赛特制药公司 用于治疗因缺钙引起的病状的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
FR2732896B1 (fr) * 1995-04-11 1997-06-13 Prographarm Lab Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine

Also Published As

Publication number Publication date
EP1270007B1 (en) 2004-05-26
EP1270007A2 (en) 2003-01-02
ATE267600T1 (de) 2004-06-15
DE60200531D1 (de) 2004-07-01
EP1270007A3 (en) 2003-03-12
ITMI20011321A1 (it) 2002-12-22

Similar Documents

Publication Publication Date Title
GEP20053673B (en) Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
DK1381352T3 (da) Plaster til transdermal indgivelse af fentanyl
ECSP066313A (es) Derivados de la piridazina y su uso como agentes terapéuticos
ATE449079T1 (de) Pharmazeutische zusammensetzungen beinhaltend kristallsalze von 7-ä4-(4-fluorophenyl)-6- isopropyl-2-
EP1965823A4 (en) METHOD FOR THE ADMINISTRATION OF HYPOGLYKEMIC AGENTS
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
GB0002336D0 (en) Medicaments
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ATE380174T1 (de) Arginin-mimetika als faktor xa-inhibitoren
SE0102440D0 (sv) New compound
PE20090625A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
ITMI20011321A0 (it) Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del
SE9900070D0 (sv) New use
SE0401655D0 (sv) New compounds
ATE380189T1 (de) 2-amino-5-benzoylthiazol npy-antagonisten
AR029666A1 (es) Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina
GEP201606538B (en) Preoperative treatment of post operative pain
SE0102057D0 (sv) New Salts I
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
RS50523B (sr) Farmaceutska kompozicija koja sadrži cink-hijaluronat kompleks za lečenje multiple skleroze
MA31100B1 (fr) Nouvelle utilisation therapeutique pour le traitement des leucemies
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
SE0102058D0 (sv) New Salts II
IT1316440B1 (it) Cannula erogatrice di unguenti medicinali.
ITRM20000433A0 (it) Uso di fibrati per la preparazione di un medicamento utile nel trattamento dell'insufficenza cardiaca congestizia.